FOXM1 and central nervous system cancer: A previous study identified FoxM1 as a downstream target of the canonical Wnt/β-catenin signaling pathway, wherein its nuclear accumulation, in conjunction with β-catenin, enhances the expression of c-Myc and Cyclin D1 in glioma cells 5.